Related Experiment Videos
Myasthenia gravis in elderly patients
The Annals of Thoracic Surgery
|May 1, 1985
Summary
Elderly and young adults with myasthenia gravis (MG) show similar thymoma stages but differing autoimmune disease associations. Thymectomy outcomes varied, with younger patients and those without thymoma experiencing better results.
Area of Science:
- Neurology
- Immunology
- Thoracic Surgery
Background:
- Myasthenia gravis (MG) is a neuromuscular autoimmune disease.
- Thymectomy is a primary treatment for MG, but outcomes may differ between age groups.
Purpose of the Study:
- To compare clinical features and thymectomy outcomes in elderly versus young adult patients with MG.
- To investigate the association with other autoimmune diseases in these patient groups.
Main Methods:
- Retrospective comparison of 27 elderly (Group 2) and 119 young adult (Group 1) MG patients.
- Analysis of MG subtypes, co-existing autoimmune diseases, thymoma stage, and 3-year post-thymectomy remission and palliation rates.
Main Results:
- MG subtypes distribution showed some differences between groups.
- Association rates with autoimmune diseases were higher in young adults (21.3%) than elderly (12.5%) patients without thymoma.
- Remission and palliation rates after thymectomy were comparable between age groups for thymoma patients, but higher in non-thymoma patients, especially the elderly (50% remission, 100% palliation).
Conclusions:
- Elderly and young adult MG patients present with varying autoimmune disease associations.
- Thymectomy offers significant palliation and remission benefits for both age groups, particularly in the absence of thymoma.